Advertisement

Topics

Teva Pharmaceutical Industries Ltd. Slashes Full-Year Outlook After Disappointing Second Quarter

12:50 EDT 3 Aug 2017 | Topix

The big generic and specialty drugmaker struggled in the second quarter due to challenges for its U.S. generics business and Venezuelan uncertainty. Teva announced its second-quarter results before the market opened on Thursday.

Original Article: Teva Pharmaceutical Industries Ltd. Slashes Full-Year Outlook After Disappointing Second Quarter

NEXT ARTICLE

More From BioPortfolio on "Teva Pharmaceutical Industries Ltd. Slashes Full-Year Outlook After Disappointing Second Quarter"

Quick Search
Advertisement
 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...